Log In
BCIQ
Print this Print this
 

Minocycline foam (FMX-101) (formerly FXFM244)

  Manage Alerts
Collapse Summary General Information
Company Foamix Pharmaceuticals Ltd.
DescriptionTopical foam formulation of 4% minocycline
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAcne
Indication DetailsTreat moderate to severe acne
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today